idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
24.08.2018 11:09

Protection For Nerve Cells Delivered Through The Nose

Marietta Fuhrmann-Koch Kommunikation und Marketing
Universität Heidelberg

    Protective proteins that mitigate the destruction of nerve cells after a stroke can be administered into the brain through the nose, as Heidelberg University researchers demonstrated using a mouse model. The team led by Prof. Dr Hilmar Bading at the Interdisciplinary Center for Neurosciences (IZN) is laying the scientific groundwork for new forms of therapy that inhibit degenerative processes in humans. Prof. Bading's team is concentrating on the body's own neuroprotective mechanisms. The most recent results of their work were published in “Molecular Therapy”.

    Press Release
    Heidelberg, 24. August 2018

    Protection For Nerve Cells Delivered Through The Nose
    Researchers work on scientific foundation for new forms of therapy in neurodegenerative processes

    Protective proteins that mitigate the destruction of nerve cells after a stroke can be administered into the brain through the nose, as Heidelberg University researchers demonstrated using a mouse model. The team led by Prof. Dr Hilmar Bading at the Interdisciplinary Center for Neurosciences (IZN) is laying the scientific groundwork for new forms of therapy that inhibit degenerative processes in humans. Prof. Bading's team is concentrating on the body's own neuroprotective mechanisms. The most recent results of their work were published in “Molecular Therapy”.

    In earlier studies, the Heidelberg researchers showed that brain activity counteracts nerve cell death. “We know that activated nerve cells produce proteins that guard against cell death,” Prof. Bading explains. At the molecular level, the NMDA receptor plays a key role. If these receptors are not located in the nerve cell junctions, or synapses, they can cause massive cell damage and death. However, the toxic extrasynaptic NMDA receptors and the consequences of their activation can be suppressed. The neurobiologist's research group discovered that the proteins that trigger this suppression, Activin A and SerpinB2, are produced in the nervous system in response to brain activity.

    The researchers were particularly interested in how these protective proteins could be administered from the “outside” when their production via activated nerve cells is low, such as after a stroke. In cooperation with Dr Bettina Buchthal and Ursula Weiß, Prof. Bading was able to demonstrate that nasal administration paves the way for new treatment approaches for neurodegenerative diseases. They verified this concept using a mouse model. According to Hilmar Bading, mice who received this treatment exhibited less brain damage after a stroke in certain regions of the brain.

    Thus, the researchers laid the scientific foundation for a simple “nasal spray” that could reduce the disease-related loss of nerve cells. “Unfortunately, it will take many more years before clinical applications in humans are possible. There are a number of testing phases that must be passed before a new compound is approved as a therapeutic drug,” Prof. Bading adds. The researcher believes that this “non-invasive and extraordinarily simple treatment principle” would be effective not only in cases of acute post-stroke brain damage. It may also help in chronic neurodegenerative diseases associated with increased activation of extrasynaptic NMDA receptors, which includes amyotrophic lateral sclerosis (ALS), Alzheimer's and Huntington's disease.

    Contact:
    Heidelberg University
    Communications and Marketing
    Press Office, phone +49 6221 54-2311
    presse@rektorat.uni-heidelberg.de


    Wissenschaftliche Ansprechpartner:

    Prof. Dr. Hilmar Bading
    Interdisciplinary Center for Neurosciences
    Phone +49 06221 54-8218
    bading@nbio.uni-heidelberg.de


    Originalpublikation:

    B. Buchthal, U. Weiss and H. Bading: Post-injury Nose-to-Brain Delivery of Activin A and SerpinB2 Reduces Brain Damage in a Mouse Stroke Model. Molecular Therapy (published online 23 July 2018), https://doi.org/10.1016/j.ymthe.2018.07.018


    Weitere Informationen:

    http://www.uni-heidelberg.de/izn/researchgroups/bading
    http://www.uni-heidelberg.de/presse/indexnews.en.html


    Bilder

    Merkmale dieser Pressemitteilung:
    Journalisten
    Biologie, Medizin
    überregional
    Forschungsergebnisse
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).